ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,187.70
0.13%
US Tech 100
17,618.80
0.05%
다우존스 지수
38,884.26
0.08%
Bitcoin
62,551.69
0.35%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Medicenna Therapeutics Corporation (MDNA)

  7. Medicenna Therapeutics Corporation (MDNA) 뉴스

MDNA Medicenna Therapeutics Corporation

0.157
0.00 (0.00%)
07 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Medicenna Therapeutics Corporation MDNA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 0.157 09:00:00
개장가 저가 고가 종가 전일 종가
0.157 0.157
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202404:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/04/202404:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/04/202403:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/04/202405:40EDGAR2Form AW - Amendment Withdrawal Request
17/04/202406:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/04/202406:05EDGAR2Form F-3/A - Registration statement by foreign private..
17/04/202406:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
10/04/202403:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/04/202403:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/02/202421:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/01/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/01/202400:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/01/202423:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/12/202304:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202322:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
09/11/202300:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202321:00GLOBEMedicenna Announces Promising Single-Agent Response and..
04/11/202301:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202320:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
26/10/202304:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202320:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202320:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202320:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202321:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202320:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
04/10/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202320:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
29/09/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/09/202306:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/09/202323:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/09/202320:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/09/202320:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/09/202320:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
29/08/202305:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/08/202305:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/08/202320:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
15/08/202305:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/08/202320:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
10/08/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/08/202322:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/08/202320:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/08/202321:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/08/202320:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
02/08/202301:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/08/202322:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/07/202321:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/07/202320:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/07/202321:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/07/202320:00GLOBEMedicenna Presents at National Brain Tumor Society's..
06/07/202323:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

NASDAQ
MDNA
Medicenna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유